Haleos Labs (NSE:HALEOSLABS) FCF Margin %: 0.00% (As of Mar. 2026)


NSE:HALEOSLABS Haleos Labs Ltd NSE:HALEOSLABS
72 GF Score
Price ₹1,612.30
GF Value ₹1,123.78
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Haleos Labs FCF Margin %?

Haleos Labs NSE:HALEOSLABS -0.50% 72 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:HALEOSLABS with a GF Score™ of 72/100 and a GF Value™ of ₹1,123.78 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 947 Biotechnology companies, Haleos Labs ranks better than 70.22% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Haleos Labs's Free Cash Flow for the three months ended in Mar. 2026 was ₹0 Mil. Haleos Labs's Revenue for the three months ended in Mar. 2026 was ₹751 Mil. Therefore, Haleos Labs's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Haleos Labs's current FCF Yield % is -4.32%.

The historical rank and industry rank for Haleos Labs's FCF Margin % or its related term are showing as below:

NSE:HALEOSLABS' s FCF Margin % Range Over the Past 10 Years
Min: -17.97   Med: 0.5   Max: 5.7
Current: -6.18


During the past 11 years, the highest FCF Margin % of Haleos Labs was 5.70%. The lowest was -17.97%. And the median was 0.50%.

NSE:HALEOSLABS's FCF Margin % is ranked better than
70.22% of 947 companies
in the Biotechnology industry
Industry Median: -82.65 vs NSE:HALEOSLABS: -6.18


Haleos Labs FCF Margin % Related Terms


Haleos Labs FCF Margin % Historical Data

* Premium members only.

The historical data trend for Haleos Labs's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleos Labs FCF Margin % Chart

Haleos Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.97 -10.83 1.15 5.43 -6.18

Haleos Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:HALEOSLABS vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Haleos Labs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haleos Labs FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Haleos Labs's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Haleos Labs's FCF Margin % falls into.


NSE:HALEOSLABS
72GF Score
Haleos Labs Ltd NSE:HALEOSLABS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleos Labs FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Haleos Labs's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-206.386/3337.945
=-6.18 %

Haleos Labs's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/751.391
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Haleos Labs (NSE:HALEOSLABS) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Haleos Labs and its competitors. According to the industry distribution chart, Haleos Labs ranks #282 out of 947 companies in the Biotechnology industry, placing it in the top 29.8%.
Is Haleos Labs' FCF Margin % too high?
Haleos Labs' current FCF Margin % is 0.00%. Based on the distribution chart, Haleos Labs ranks #282 out of 947 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Haleos Labs has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Haleos Labs' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Haleos Labs ranks #282 out of 947 companies for FCF Margin %. This puts Haleos Labs in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Haleos Labs and its competitors. Haleos Labs's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleos Labs stock overvalued right now?
Based on GuruFocus' analysis, Haleos Labs (NSE:HALEOSLABS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,123.78, compared to a current price of ₹1,612.30 — trading 43.5% above its estimated fair value. The current FCF Margin % is 0.00%. Haleos Labs' overall GF Score™ is 72/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Haleos Labs (NSE:HALEOSLABS), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleos Labs (NSE:HALEOSLABS) Overvalued in 2026?

Based on GuruFocus' analysis, Haleos Labs stock appears to be overvalued. The current stock price of ₹1,612.30 is trading 43.5% above its estimated GF Value™ of ₹1,123.78. GuruFocus considers Haleos Labs to be Significantly Overvalued.

Key valuation signals for NSE:HALEOSLABS:

  • FCF Margin %: 0.00%
  • GF Value™: ₹1,123.78 vs. price of ₹1,612.30 (43.5% above fair value)
  • GF Score™: 72/100 with 10 warning signs

No single metric tells the full story. See the NSE:HALEOSLABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Haleos Labs Business Description

Other Exchanges 540679:India
Address Road Number 71, Plot Number 19 - III, Opposite Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad, TG, IND, 500096
Haleos Labs Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
72GF Score

Get the complete analysis for NSE:HALEOSLABS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,612.30
Price
₹1,123.78
GF Value